Anabelle Colaco
01 Aug 2025, 09:10 GMT+10
WASHINGTON, D.C.: Vinay Prasad, the chief medical and science officer at the U.S. Food and Drug Administration (FDA), has left the agency, according to the U.S. Department of Health and Human Services (HHS), which confirmed his departure.
"Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family," an HHS spokesperson said in an emailed statement to Reuters. "We thank him for his service and the many important reforms he was able to achieve in his time at the FDA."
His resignation follows a series of controversial decisions involving the FDA's handling of Elevidys, a gene therapy developed by Sarepta Therapeutics for Duchenne muscular dystrophy. The agency initially paused distribution of the treatment after the deaths of several patients but reversed the suspension earlier this week.
STAT News was the first to report Prasad's departure. The outlet previously noted in June that Prasad had been named to the FDA's top science post, citing an internal memo.
In May, Prasad, an oncologist known for publicly criticizing FDA leadership and COVID-19 policies, was also appointed director of the FDA's Center for Biologics Evaluation and Research.
Get a daily dose of Milwaukee Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Milwaukee Sun.
More InformationThe Trump administration moved Thursday to deny visas to Palestinian officials, accusing them of sabotaging peace efforts, a stark...
MOSCOW, Russia: One of the most powerful earthquakes ever recorded — measuring 8.8 in magnitude — struck off the remote coast of Russia's...
WASHINGTON, D.C.: Vinay Prasad, the chief medical and science officer at the U.S. Food and Drug Administration (FDA), has left the...
WASHINGTON, D.C.: The Federal Emergency Management Agency (FEMA) has introduced a new rule requiring states to dedicate a portion of...
SEOUL, South Korea: With just a day left before a critical August 1 deadline, South Korea is pulling out all the stops to strike a...
WELLINGTON, New Zealand: On July 29, the New Zealand government introduced a controversial bill that would restrict voting access by...
(Photo credit: Matt Kartozian-Imagn Images) Shelby Miller is on his way back to the Milwaukee organization for the third time and...
(Photo credit: Wm. Glasheen/USA TODAY NETWORK-Wisconsin / USA TODAY NETWORK via Imagn Images) The San Diego Padres obtained left-handed...
(Photo credit: Charles LeClaire-Imagn Images) The Tampa Bay Rays bolstered their pitching staff on Thursday in a deal that resulted...
(Photo credit: Charles LeClaire-Imagn Images) The World Series is always the motivator when teams pursue trades at the deadline....
(Photo credit: Wm. Glasheen/USA TODAY NETWORK-Wisconsin / USA TODAY NETWORK via Imagn Images) The San Diego Padres obtained left-handed...
(Photo credit: Nathan Ray Seebeck-Imagn Images) The Indianapolis Colts addressed their thinning secondary by signing free agent cornerbacks...